Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVO

Novo Nordisk ADR

Feb 09 • 04:00PM ET

49.37

+1.73 3.63 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Feb 09, 3:50 PMNovo Nordisk ADRs rise as it launches its previously announced DKK 15 billion, 12-month share buyback starting Feb. 4, 2026, while the FDA calls Wegovy TV ads false or misleading and the company pursues a Delaware patent suit against Hims & Hers over alleged mass-marketing of unapproved compounded Wegovy and Ozempic after Hims & Hers scrapped plans for a low-cost compounded Wegovy pill amid FDA GLP-1 restrictions and Novo’s legal threats.

Peers: LLY MRK ABBV JNJ AMGN AZN-D PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI PID WCMI PINK OZEM AQEC APIE

Scroll to Statements

Index	-	P/E	14.24	EPS (ttm)	3.47	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-16.22%
Market Cap	166.33B	Forward P/E	14.08	EPS next Y	3.51	Insider Trans	-	Shs Float	3.37B	Perf Month	-13.90%
Enterprise Value	182.69B	PEG	6.32	EPS next Q	0.82	Inst Own	9.05%	Short Float	0.84%	Perf Quarter	6.15%
Income	15.45B	P/S	3.56	EPS this Y	-7.05%	Inst Trans	-1.17%	Short Ratio	1.28	Perf Half Y	-3.35%
Sales	46.77B	P/B	7.19	EPS next Y	3.65%	ROA	20.59%	Short Interest	28.16M	Perf YTD	-2.97%
Book/sh	6.87	P/C	39.23	EPS next 5Y	2.23%	ROE	61.25%	52W High	93.80 -47.37%	Perf Year	-43.36%
Cash/sh	1.26	P/FCF	18.58	EPS past 3/5Y	26.28% 20.36%	ROIC	31.38%	52W Low	43.08 14.60%	Perf 3Y	-25.39%
Dividend Est.	1.68 (3.41%)	EV/EBITDA	8.08	Sales past 3/5Y	23.19% 19.21%	Gross Margin	80.90%	Volatility	7.41% 3.92%	Perf 5Y	39.13%
Dividend TTM	1.73 (3.50%)	EV/Sales	3.91	EPS Y/Y TTM	5.57%	Oper. Margin	41.17%	ATR (14)	2.89	Perf 10Y	76.83%
Dividend Ex-Date	Mar 30, 2026	Quick Ratio	0.57	Sales Y/Y TTM	11.11%	Profit Margin	33.03%	RSI (14)	40.63	Recom	2.26
Dividend Gr. 3/5Y	28.28% 20.66%	Current Ratio	0.80	EPS Q/Q	3.95%	SMA20	-13.77%	Beta	0.69	Target Price	59.06
Payout	38.07%	Debt/Eq	0.67	Sales Q/Q	0.66%	SMA50	-7.29%	Rel Volume	1.37	Prev Close	47.64
Employees	68794	LT Debt/Eq	0.61	Earnings	Feb 04 BMO	SMA200	-15.64%	Avg Volume	21.93M	Price	49.37
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.40% 3.10%	Trades		Volume	29,993,957	Change	3.63%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120

Show Previous Ratings

Feb-09-26 05:20PM	Stocks to Watch Monday Recap: Novo Nordisk, Hims & Hers, Apollo (The Wall Street Journal)
08:12AM	Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired. (Barrons.com)
04:19PM	These Stocks Are Todays Movers: Kyndryl, Hims & Hers, Novo Nordisk, Oracle, Nvidia, AppLovin, and More (Barrons.com)
04:15PM	Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit (Investor's Business Daily)
04:05PM	FDA Flags Novo Wegovy Pill Ad; Shares Par Gains After 8.95% Rise (GuruFocus.com)
03:44PM	Loading…
03:44PM	Novo Nordisk, Hims & Hers Health Shares React to Lawsuit (Schaeffer's Research)
03:42PM	Stocks to Watch Monday: Novo Nordisk, Hims & Hers, Apollo (The Wall Street Journal)
02:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:19PM	Novo Nordisk Escalates Fight Against Hims & Hers (The Wall Street Journal)
02:04PM	Squawk Pod: Super Bowl ads & GLP-1 competition - 02/09/26 Audio Only (CNBC TV)
01:44PM	FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast (Benzinga)
01:03PM	Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War (Benzinga)
12:28PM	Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans (Benzinga)
11:59AM	HIMs 22% Collapse Looks Like A Buy The Dip Moment (24/7 Wall St.)
11:33AM	Hims & Hers Stock Plunges While Novo Nordisk Gains as Weight-Loss Drug Wars Take New Turn (Investopedia)
11:25AM	Loading…
11:25AM	Novo sues Hims & Hers despite Wegovy pill offering U-turn (Pharmaceutical Technology)
11:22AM	Dow Jones retreat from highs as Amazon and Apple fall (Proactive)
11:06AM	Stock Market Today: Dow Gains As Nvidia Jumps; Apple Lags, Energy Stock Tests Entry (Live Coverage) (Investor's Business Daily)
11:03AM	Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pills, injections (CNBC TV)
10:49AM	Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds (Yahoo Finance)
10:24AM	HIMS Stock Tumbles as FDA Scrutiny Boosts Novo Nordisk Shares (GuruFocus.com)
10:18AM	Stock Market Today: Dow Skids Even As Nvidia Jumps; Monday Plunges, Biopharma Funds Lag (Live Coverage) (Investor's Business Daily)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
10:10AM	Novo Nordisk has had it up to here with knockoff Ozempic (Quartz)
10:06AM	Novo Nordisk sues Hims & Hers over knockoff weight loss drugs (Quartz)
10:03AM	Dr. Scott Gottlieb on Novo Nordisk vs. Hims & Hers: We have a drug approval process for a reason (CNBC TV)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
09:46AM	Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs (Benzinga)
09:44AM	Stock Market Today: Dow Falls As Jobs Report Looms; AI Player Monday Plunges On Earnings (Live Coverage) (Investor's Business Daily)
09:37AM	Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
09:28AM	Loading…
09:28AM	Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges (Yahoo Finance Video)
09:25AM	Novo Nordisk Sues Hims & Hers, Seeking Ban on Copycat Drugs and Damages (The Wall Street Journal)
09:04AM	Hims & Hers scraps low-cost weight-loss pill following backlash (Proactive)
08:07AM	Novo Nordisk Files Lawsuit Against Hims & Hers, Seeking Ban on Copycat Drugs and Damages (The Wall Street Journal)
07:39AM	Novo Nordisk Surges as Hims & Hers Withdraws Weight-Loss Pill (GuruFocus.com)
07:36AM	Hims & Hers slumps on Wegovy backtrack and more early-moving stocks (MarketWatch)
07:28AM	Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill (USA TODAY)
07:18AM	Hims & Hers Pulls Compounded Weight-Loss Pill After FDA Warning (GuruFocus.com)
06:26AM	How to Be a Better Investor? Watch Game Shows. (The Wall Street Journal)
05:11AM	Hims & Hers Stock Plunges 15%. Why Losing the Novo Wegovy Battle Is a Blow. (Barrons.com)
05:07AM	Novo Nordisk Stock Jumps After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
04:40AM	Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill (The Wall Street Journal)
04:13AM	Novo Nordisk shares rise as Hims abandons $49 weight-loss pill (Reuters)
03:53AM	Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill (Investing.com)
03:30AM	Hims & Hers Super Bowl Ad For Cancer Test Raises Questions Over Reliability (Benzinga)
03:30AM	Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor (MarketWatch)
Feb-08-26 10:27AM	Novo Nordisk A/S (NVO) Eyes Solidifying Its Market Position with Increased Advertising Spending (Insider Monkey)
08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
07:57AM	Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning (Benzinga)
04:30AM	Novo Nordisk (NVO) Faces Pricing Pressure While Defending Wegovy Franchise and Advancing Oral GLP-1s (Insider Monkey)
Feb-07-26 05:35PM	Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill (Associated Press Finance)
05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
04:22PM	Hims & Hers to Stop Offering Wegovy Copycat Drug After Regulatory Scrutiny (Barrons.com)
03:32PM	Hims & Hers abandons copycat weight-loss drug in face of FDA probe (Financial Times)
11:16AM	Hims cancels plans to sell compounded GLP-1 pill after FDA backlash (BioPharma Dive)
09:31AM	Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action (Benzinga)
06:07AM	Weight-loss drugs to compete on biggest stage with Super Bowl ads (Reuters)
05:30AM	The Weight-Loss Price Wars Are Breaking Big Pharmas Business Model (The Wall Street Journal)
12:56AM	Jim Cramer on Novo Nordisk: "It Seems Eli Lilly's Eating Their Lunch" (Insider Monkey)
Feb-06-26 10:08PM	Novo Nordisk A/S Q4 Earnings Call Highlights (MarketBeat) +9.92%
05:45PM	FDA scrutiny rattles Hims & Hers stock (Investing.com)
05:45PM	Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut (MarketBeat)
05:13PM	TrumpRx Is Here. Most People Wont Benefit. (Barrons.com)
04:13PM	Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers (Barrons.com)
03:29PM	Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill (MarketWatch)
01:51PM	What's Going On With Novo Nordisk Stock On Friday? (Benzinga)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
12:38PM	These Stocks Are Todays Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More (Barrons.com)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:52AM	Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo. (Barrons.com)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
10:41AM	Novo Nordisk Shares Slide 21% After Forecast Cut, Copycat Wegovy Pill Launch (GuruFocus.com)
10:37AM	Hims & Hers falls ~8% premarket after FDA warning on copycat drugs (GuruFocus.com)
09:27AM	NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill (Zacks)
08:22AM	Hims & Hers stock falls after FDA warns against illegal copycat drugs (Investing.com)
07:52AM	Novos Stratospheric Rise Has Turned Into a $460 Billion Wipeout (Bloomberg)
07:36AM	Novo Nordisk Rebounds After FDA Signals Crackdown on Copycat Drugs (GuruFocus.com)
07:22AM	FDA targets illegal drug copies amid latest Hims & Hers/Novo Nordisk flashpoint (Pharmaceutical Technology)
07:17AM	Citi flags lingering risks to Novo despite strong weight-loss portfolio (Proactive)
07:04AM	Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. (Barrons.com)
07:02AM	Novo Nordisk Shares Rebound as FDA Moves Against Illegal Drug Copies (GuruFocus.com)
06:05AM	These Stocks Are Today's Movers: Amazon, Strategy, Novo Nordisk, Molina Healthcare, Strategy, Roblox, Hub Group, and More (Barrons.com)
04:51AM	Novo shares rebound as FDA vows crackdown on weight-loss drug copies (Investing.com)
04:25AM	Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pill (MarketWatch)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 08:24PM	White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications (The Wall Street Journal) -8.16%
07:52PM	Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem (Investor's Business Daily)
04:53PM	These Stocks Are Todays Movers: Alphabet, Qualcomm, Broadcom, AMD, Strategy, Novo Nordisk, Amazon, and More (Barrons.com)
04:31PM	Hims Is Already Knocking Off Novo's Wegovy Pill For Just $49 A Month (Investor's Business Daily)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
04:11PM	Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks (Investopedia)
04:08PM	Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly (Reuters)
03:40PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:35PM	Nasdaq drags major indexes lower as Alphabet spending plans spook investors (Proactive)
02:11PM	Dow falls sharply, Hims' Wegovy rival, Nio's profit outlook (Yahoo Finance Video)
02:05PM	Hims & Hers Is Introducing a Cheaper Wegovy Copycat. Novo Nordisk Stock Falls. (Barrons.com)
01:30PM	Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk (Associated Press Finance)
01:22PM	Novo Nordisk vows legal action to protect Wegovy pill (AFP)
01:15PM	Hims & Hers offers cheaper weight-loss pill in a shock to Novo (Reuters Videos)
01:13PM	Novo Nordisk Threatens Legal Action Over Hims & Hers' Wegovy Alternative (GuruFocus.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience